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vular tensor apparatus was managed at op-
eration. Left ventricular function is unques-
tionably related to this. At least in the
context of randomized controlled trials,
complete preservation of the apparatus re-
sults in better left ventricular perfor-
mance,4 which also means a lower chance
of thrombus and later embolism develop-
ment.5 This generates another confounding
factor when interpreting the data. Third, the
underlying strategy for anticoagulation
control should be addressed and controlled
for in the inclusion criteria. Finally, the
presence or absence of perioperative atrial
fibrillation is acknowledged as important
by both operating surgeons manufacturers.
It is possible that these factors were
considered; however, for the sake of the
reader, it is necessary to be include them in
the discussion. Such consideration will re-
duce chance-related outcome and broaden
the horizon of the reader when transferring
a statistical critique to clinical reality.
Jeffrey H. Shuhaiber, MD
Malek Massad, MD
Alexander Geha, MD
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Reply to the Editor:
We thank Dr Shuhaiber and colleagues for
their comments on our study comparing
two heart valve models on the basis of
reports from the literature. In describing
the limitations of such comparisons, they
give us another opportunity to stress the
main purpose of our report, which was to
point out precisely these limitations.
The ideal way to compare valve perfor-
mance across multiple studies is to use
risk-adjustment techniques with individual,
patient-level data. But only summary,
study-level information is available from
published reports. We emphasized also that
the simple, weighted-average pooling of
results within valve types is not appropriate
if these results are statistically heteroge-
neous.
A regression approach that does allow
for heterogeneity was used to adjust for
some series-level risk factors: the mean,
maximum, and completeness of follow-up;
bleeding rate, as a surrogate for anticoagu-
lation intensity; mean age; percentage of
male patients; year of publication; number
of valves; and journal impact factor. Three
of the risk factors that Dr Shuhaiber men-
tions, etiology, surgical technique and
atrial fibrillation, were generally not avail-
able in these reports.
It can be seen from the plots of linear-
ized rates that by arbitrarily selecting
groups of studies, the superiority of either
valve in either position for any of the three
outcomes studied can be supported. Be-
cause there is a tendency to perform these
literature comparisons despite the de-
scribed limitations, we used statistical tech-
niques that can account for some of these
limitations. We also stressed the “cautious
interpretation” of even the most carefully
done comparisons.
Gary L. Grunkemeier, PhD
YingXing Wu, MD
Providence Health System
9155 SW Barnes, Suite 33
Portland, OR 97225
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Esophageal perforation during left
atrial radiofrequency ablation: Is the
risk too high?
To the Editor:
The recent article by Doll and colleagues
documents a 1% incidence of esophageal
perforation with intraoperative radiofre-
quency ablation of atrial fibrillation (AF).1
This observation serves as an important
word of caution as we increase the appli-
cation of surgical ablation and design min-
imally invasive procedures to treat AF. In
our exploration of new approaches to
cure AF, we must first follow the edict
“do no harm.” Although AF is an unde-
sirable and dangerous heart rhythm, we
cannot justify major complications in its
treatment.
The esophageal injuries described by
Doll and colleagues resulted from the ap-
plication of a heat-based energy source to
the left atrial endocardium. In each case,
the esophagus, which courses posterior to
the left atrium, suffered a burn with result-
ing esophageal perforation. They note that
this complication has occurred with unipo-
lar radiofrequency and microwave ener-
gies.1,2 It is likely that collateral damage in
general and esophageal injury in particular
will occur occasionally with any heat-
based, endocardial approach to AF ablation
that lacks precise control of lesion depth
and direction.
Safety in AF ablation requires that the
depth of tissue injury be controlled during
ablation; delivery of energy must be fo-
cused and directed to avoid collateral dam-
age. In addition, however, it is generally
accepted that efficacy requires transmural
atrial lesions. There are several promising
modalities that satisfy both of these crite-
ria. Safety may be reliably achieved with
bipolar or epicardial energy delivery. Bipo-
lar radiofrequency devices ablate only the
tissue between the jaws of the clamp, elim-
inating the risk of esophageal injury.3 Epi-
cardial delivery of energy with a shielded,
directional catheter is also an attractive op-
tion. Epicardial ablation using ultrasound
energy may have particular advantages, as
this energy source allows reliable creation
of a lesion that is 10 mm in depth and
design of the ultrasound catheter ensures
directional delivery of energy from the epi-
cardium to the endocardium.
As surgeons explore these technologies
and devise new procedures to cure AF, we
must follow the lead of the group from
Leipzig and share our experiences, whether
they be favorable or unfavorable. This
strategy will facilitate development of ef-
fective and safe procedures to ablate AF.
And this, in turn, will offer the possibility
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